Showing 7791-7800 of 10619 results for "".
- Study Suggests Preoperative Iron Infusions Work Better Than Blood Transfusions for Some Anemic Patientshttps://reachmd.com/news/study-suggests-preoperative-iron-infusions-work-better-than-blood-transfusions-for-some-anemic-patients/2467540/In a rigorous medical records study covering tens of thousands of patients, Johns Hopkins Medicine researchers conclude that some patients with preoperative anemia have better outcomes if they get iron infusions before surgery rather than standard red blood cell
- Cellular Therapy Receives FDA Fast Track Designation for Potential Treatment of Alzheimer Diseasehttps://reachmd.com/news/cellular-therapy-receives-fda-fast-track-designation-for-potential-treatment-of-alzheimer-disease/2467567/Lomecel-B (Longeveron, Miami, Fl), an allogenic cellular therapy, has been granted Fast Track Designation by the Food and Drug Administration (FDA) for investigation for potential applications in Alzheimer disease (AD), aging-related frailty, and hypoplastic left heart syndrome. The
- Research Finds No Difference in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Prevalence Caused by COVID-19 and Other Acute Illnesseshttps://reachmd.com/news/research-finds-no-difference-in-myalgic-encephalomyelitischronic-fatigue-syndrome-prevalence-caused-by-covid-19-and-other-acute-illnesses/2467502/A new study led by UCLA finds that rates of subsequent myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) following an acute illness were roughly the same between people whose acute illness was due to COVID-19 and those who did not have COVID-19.Researchers of the
- Weekly Cendakimab Dosing Effective in Reducing AD Severityhttps://reachmd.com/news/weekly-cendakimab-dosing-effective-reducing-ad-severity/2467489/New research shows that cendakimab is safe and efficacious at certain dosing levels over a 16-week study period in patients with moderate-to-severe atopic dermatitis (AD). The study authors for the phase 2 trial included 221 adult patients with moderate-to-severe AD from the United States
- Pfizer's ATTR Heart Disease Drug Needs Hefty Discount, Says ICER Draft Report. What About Alnylam's Amvuttra?https://reachmd.com/news/pfizers-attr-heart-disease-drug-needs-hefty-discount-says-icer-draft-report-what-about-alnylams-amvuttra/2467473/Pfizer’s blockbuster drug tafamidis for the treatment of the rare heart disease transthyretin amyloid cardiomyopathy (ATTR-CM) needs at least a 96% discount off its list price to be considered cost-effective under common benchmarks. The finding came from a
- Preclinical Model Offers New Insights into Parkinson's Disease Processhttps://reachmd.com/news/preclinical-model-offers-new-insights-into-parkinsons-disease-process/2467465/A new preclinical model offers a unique platform for studying the Parkinson's disease process and suggests a relatively easy method for detecting the disease in people, according to a new study led by Weill Cornell Medicine researchers. In the study, published July 23 in
- Study Evaluates Treatment Interventions for Severe Obesity in Adolescentshttps://reachmd.com/news/study-evaluates-treatment-interventions-for-severe-obesity-in-adolescents/2467468/Justin Ryder, PhD, associate professor of Surgery in the Division of Pediatric Surgery and of Pediatrics, was a co-author of the s
- New Study Shows Updated Stroke Evaluation Protocols Increase Patient Access to Lifesaving Stroke Treatmenthttps://reachmd.com/news/new-study-shows-updated-stroke-evaluation-protocols-increase-patient-access-to-lifesaving-stroke-treatment/2467460/by Society of NeuroInterventional Surgery
- Finding a Solution for Long COVID, One Cell Type at a Timehttps://reachmd.com/news/finding-a-solution-for-long-covid-one-cell-type-at-a-time/2467482/A 2022 study suggesting that blocking a single molecule could protect against severe illness in COVID-19 has led to a $15 million federal gr
- Investigational Intradiscal Injection Improved Pain Associated with Lumbar Disc Herniationhttps://reachmd.com/news/investigational-intradiscal-injection-improved-pain-associated-with-lumbar-disc-herniation/2467449/People treated with experimental product SI-6603 (condoliase; Ferring Pharmaceuticals, Parsippany, NJ; Seikagaku, Tokyo, Japan) by a single intradiscal injection showed improvements in the radicular leg pain associated with their lumbar disc herniation (LDH). Early resp